Treat FTD Fund
Funds early-stage clinical studies for frontotemporal dementia, including prevention trials for high-risk participants.
Eligibility · Global — open worldwide
⚠ This may reflect a past cycle — verify the current call on the funder's site.
The Treat FTD Fund is a joint clinical-trials funding program operated by the Alzheimer's Drug Discovery Foundation (ADDF) and the Association for Frontotemporal Degeneration (AFTD), addressing the critical shortage of interventional studies for frontotemporal degeneration disorders — a rare disease cluster affecting approximately 50,000 to 60,000 Americans with no approved disease-modifying treat…
Phase 0, 1, or 2 clinical trials for frontotemporal degeneration disorders. Prevention trials in presymptomatic at-risk individuals also eligible. IND-enabling work must be completed or near-complete.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see the timeline